Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-03

Clinical Trial Update: Vibrotactile Coordinated Reset for Parkinsons Patients Who Are on Dopaminergic Medication [NA]

View source ↗

Summary

A Stanford-led clinical trial is evaluating vibrotactile Coordinated Reset stimulation for Parkinson's disease patients on dopaminergic therapy; recruitment has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Parkinson Disease, Idiopathic | NA | Status: NOT_YET_RECRUITING